首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Pharmaceutical medicine

缩写:

ISSN:1178-2595

e-ISSN:1179-1993

IF/分区:4.7/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引316条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Christopher Felix Brewer Christopher Felix Brewer
Background and objectives: Efficient and informed patient recruitment, followed by successful enrolment, is essential for the conduct of clinical trials. As major stakeholders in the research process, pharmaceutical compa...
Margaret Haney,Ziva D Cooper,Hannah VanLaanen et al. Margaret Haney et al.
Background and objectives: There is increased interest in using cannabinoid-based products for therapeutic purposes. Because of unique regulatory challenges associated with these products, understanding the state of curre...
Elaine Lau,Alicia Koo,Han Byul Kang et al. Elaine Lau et al.
Background: The growing number of indications and patent expirations for biologic drugs has created opportunities for market expansion of biosimilars; however, biosimilar uptake in children has lagged behind adults. There...
Amit Dang,Sameera Tak Amit Dang
The Joint Clinical Assessment is a crucial development under the European Union Health Technology Assessment Regulation (EU HTAR, 2021/2282), aimed at standardizing clinical assessments across the Member States. This review explores the opp...
Manuel Leal Beckouche,Gustavo Resler Plat,Jorge A Marinich et al. Manuel Leal Beckouche et al.
The evolving role of Medical Affairs (MA) has positioned this department as a key element in the development and lifecycle management of pharmaceutical products. In response to internal and external assessments, AstraZeneca (AZ) Spain imple...
Riaz Abbas,Orin Chisholm,Victoria Elegant et al. Riaz Abbas et al.
Background and objectives: The biopharmaceutical industry requires fast role adaptation and comprehensive competency development to thrive in a rapidly evolving and challenging environment. Whilst competency frameworks ex...
Leping Kong,Ben Grobman,Arian Mansur et al. Leping Kong et al.
Tissue-agnostic therapies, which target molecular alterations across cancer types, have been approved by the US Food and Drug Administration (FDA) since 2017. These approvals were based on clinical trials enrolling patients across diverse t...